COVID-19 Impact on Decoagulant Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Decoagulant Industry
1.7 COVID-19 Impact: Decoagulant Market Trends
2 Global Decoagulant Quarterly Market Size Analysis
2.1 Decoagulant Business Impact Assessment - COVID-19
2.1.1 Global Decoagulant Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Decoagulant Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Decoagulant Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Decoagulant Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Decoagulant Factory Price by Manufacturers
3.3 Location of Key Manufacturers Decoagulant Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Decoagulant Market
3.5 Key Manufacturers Decoagulant Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Decoagulant Segments, By Type
4.1 Introduction
1.4.1 Platelet aggregation inhibitors (PAI)
1.4.2 Low-molecular-weight Heparin (LMWH)
1.4.3 Direct thrombin inhibitor (DTI)
1.4.4 Direct factor Xa inhibitors (DFXa)
1.4.5 Vitamin K antagonists (VKA)
1.4.6 Others
4.2 By Type, Global Decoagulant Market Size, 2019-2021
4.2.1 By Type, Global Decoagulant Market Size by Type, 2020-2021
4.2.2 By Type, Global Decoagulant Price, 2020-2021
5 Impact of Covid-19 on Decoagulant Segments, By Application
5.1 Overview
5.5.1 VTE
5.5.2 ACS/MI
5.5.3 AF
5.5.4 Others
5.2 By Application, Global Decoagulant Market Size, 2019-2021
5.2.1 By Application, Global Decoagulant Market Size by Application, 2019-2021
5.2.2 By Application, Global Decoagulant Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Business Overview
7.1.2 Sanofi Decoagulant Quarterly Production and Revenue, 2020
7.1.3 Sanofi Decoagulant Product Introduction
7.1.4 Sanofi Response to COVID-19 and Related Developments
7.2 Bayer
7.2.1 Bayer Business Overview
7.2.2 Bayer Decoagulant Quarterly Production and Revenue, 2020
7.2.3 Bayer Decoagulant Product Introduction
7.2.4 Bayer Response to COVID-19 and Related Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Business Overview
7.3.2 Boehringer Ingelheim Decoagulant Quarterly Production and Revenue, 2020
7.3.3 Boehringer Ingelheim Decoagulant Product Introduction
7.3.4 Boehringer Ingelheim Response to COVID-19 and Related Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Business Overview
7.4.2 Johnson & Johnson Decoagulant Quarterly Production and Revenue, 2020
7.4.3 Johnson & Johnson Decoagulant Product Introduction
7.4.4 Johnson & Johnson Response to COVID-19 and Related Developments
7.5 Genentech (Roche)
7.5.1 Genentech (Roche) Business Overview
7.5.2 Genentech (Roche) Decoagulant Quarterly Production and Revenue, 2020
7.5.3 Genentech (Roche) Decoagulant Product Introduction
7.5.4 Genentech (Roche) Response to COVID-19 and Related Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Business Overview
7.6.2 AstraZeneca Decoagulant Quarterly Production and Revenue, 2020
7.6.3 AstraZeneca Decoagulant Product Introduction
7.6.4 AstraZeneca Response to COVID-19 and Related Developments
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Business Overview
7.7.2 Bristol-Myers Squibb Decoagulant Quarterly Production and Revenue, 2020
7.7.3 Bristol-Myers Squibb Decoagulant Product Introduction
7.7.4 Bristol-Myers Squibb Response to COVID-19 and Related Developments
7.8 Aspen
7.8.1 Aspen Business Overview
7.8.2 Aspen Decoagulant Quarterly Production and Revenue, 2020
7.8.3 Aspen Decoagulant Product Introduction
7.8.4 Aspen Response to COVID-19 and Related Developments
7.9 Lilly
7.9.1 Lilly Business Overview
7.9.2 Lilly Decoagulant Quarterly Production and Revenue, 2020
7.9.3 Lilly Decoagulant Product Introduction
7.9.4 Lilly Response to COVID-19 and Related Developments
7.10 Otsuka
7.10.1 Otsuka Business Overview
7.10.2 Otsuka Decoagulant Quarterly Production and Revenue, 2020
7.10.3 Otsuka Decoagulant Product Introduction
7.10.4 Otsuka Response to COVID-19 and Related Developments
7.11 Pfizer
7.11.1 Pfizer Business Overview
7.11.2 Pfizer Decoagulant Quarterly Production and Revenue, 2020
7.11.3 Pfizer Decoagulant Product Introduction
7.11.4 Pfizer Response to COVID-19 and Related Developments
7.12 Daiichi Sankyo
7.12.1 Daiichi Sankyo Business Overview
7.12.2 Daiichi Sankyo Decoagulant Quarterly Production and Revenue, 2020
7.12.3 Daiichi Sankyo Decoagulant Product Introduction
7.12.4 Daiichi Sankyo Response to COVID-19 and Related Developments
7.13 The Medicines Company
7.13.1 The Medicines Company Business Overview
7.13.2 The Medicines Company Decoagulant Quarterly Production and Revenue, 2020
7.13.3 The Medicines Company Decoagulant Product Introduction
7.13.4 The Medicines Company Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Decoagulant Supply Chain Analysis
8.1.1 Decoagulant Supply Chain Analysis
8.1.2 Covid-19 Impact on Decoagulant Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Decoagulant Distribution Channels
8.2.2 Covid-19 Impact on Decoagulant Distribution Channels
8.2.3 Decoagulant Distributors
8.3 Decoagulant Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Decoagulant Assessment
Table 9. COVID-19 Impact: Decoagulant Market Trends
Table 10. COVID-19 Impact Global Decoagulant Market Size
Table 11. Global Decoagulant Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Doses)
Table 12. Global Decoagulant Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Dose)
Table 13. Global Decoagulant Quarterly Market Size, 2020 (US$ Million) & (K Doses)
Table 14. Global Decoagulant Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Decoagulant Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Doses)
Table 16. Global Decoagulant Market Growth Drivers
Table 17. Global Decoagulant Market Restraints
Table 18. Global Decoagulant Market Opportunities
Table 19. Global Decoagulant Market Challenges
Table 20. Key Manufacturers Decoagulant Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Decoagulant Market Size, 2019 (K Doses) & (US$ Million)
Table 22. Decoagulant Factory Price by Manufacturers 2020 (USD/Dose)
Table 23. Location of Key Manufacturers Decoagulant Manufacturing Plants
Table 24. Key Manufacturers Decoagulant Market Served
Table 25. Date of Key Manufacturers Enter into Decoagulant Market
Table 26. Key Manufacturers Decoagulant Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Decoagulant Market Size by Type, 2020, (US$ Million)
Table 29. Global Decoagulant Market Size by Type, 2020 (K Doses)
Table 30. Global Decoagulant Price: by Type, 2020-2021 (USD/Dose)
Table 31. Global Decoagulant Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Decoagulant Market Size by Application, 2020-2021 (K Doses)
Table 33. Global Decoagulant Price: by Application, 2020-2021 (USD/Dose)
Table 34. Global Decoagulant Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Decoagulant Market Size by Region, 2019-2021 (K Doses)
Table 36. By Country, North America Decoagulant Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Decoagulant Market Size, 2019-2021 (K Doses)
Table 38. US Decoagulant Market Size, 2019-2021 (US$ Million) & (K Doses)
Table 39. Canada Decoagulant Market Size, 2019-2021 (US$ Million) & (K Doses)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Decoagulant Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Decoagulant Market Size, 2019-2021 (K Doses)
Table 43. Germany Decoagulant Market Size, 2019-2021 (US$ Million) & (K Doses)
Table 44. France Decoagulant Market Size, 2019-2021 (US$ Million) & (K Doses)
Table 45. UK Decoagulant Market Size, 2019-2021 (US$ Million) & (K Doses)
Table 46. Italy Decoagulant Market Size, 2019-2021 (US$ Million) & (K Doses)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Decoagulant Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Decoagulant Market Size, 2019-2021 (K Doses)
Table 50. China Decoagulant Market Size, 2019-2021 (US$ Million) & (K Doses)
Table 51. Japan Decoagulant Market Size, 2019-2021 (US$ Million) & (K Doses)
Table 52. South Korea Decoagulant Market Size, 2019-2021 (US$ Million) & (K Doses)
Table 53. India Decoagulant Market Size, 2019-2021 (US$ Million) & (K Doses)
Table 54. ASEAN Decoagulant Market Size, 2019-2021 (US$ Million) & (K Doses)
Table 55. Latin America Decoagulant Market Size, 2019-2021 (US$ Million) & (K Doses)
Table 56. Middle East and Africa Decoagulant Market Size, 2019-2021 (US$ Million) & (K Doses)
Table 57. Sanofi Business Overview
Table 58. Sanofi Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Sanofi Decoagulant Product
Table 60. Sanofi Response to COVID-19 and Related Developments
Table 61. Bayer Business Overview
Table 62. Bayer Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Bayer Decoagulant Product
Table 64. Bayer Response to COVID-19 and Related Developments
Table 65. Boehringer Ingelheim Business Overview
Table 66. Boehringer Ingelheim Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Boehringer Ingelheim Decoagulant Product
Table 68. Boehringer Ingelheim Response to COVID-19 and Related Developments
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Johnson & Johnson Decoagulant Product
Table 72. Johnson & Johnson Response to COVID-19 and Related Developments
Table 73. Genentech (Roche) Business Overview
Table 74. Genentech (Roche) Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Genentech (Roche) Decoagulant Product
Table 76. Genentech (Roche) Response to COVID-19 and Related Developments
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. AstraZeneca Decoagulant Product
Table 80. AstraZeneca Response to COVID-19 and Related Developments
Table 81. Bristol-Myers Squibb Business Overview
Table 82. Bristol-Myers Squibb Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Bristol-Myers Squibb Decoagulant Product
Table 84. Bristol-Myers Squibb Response to COVID-19 and Related Developments
Table 85. Aspen Business Overview
Table 86. Aspen Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Aspen Decoagulant Product
Table 88. Aspen Response to COVID-19 and Related Developments
Table 89. Lilly Business Overview
Table 90. Lilly Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Lilly Decoagulant Product
Table 92. Lilly Response to COVID-19 and Related Developments
Table 93. Otsuka Business Overview
Table 94. Otsuka Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Otsuka Decoagulant Product
Table 96. Otsuka Response to COVID-19 and Related Developments
Table 97. Pfizer Business Overview
Table 98. Pfizer Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Pfizer Decoagulant Product
Table 100. Pfizer Response to COVID-19 and Related Developments
Table 101. Daiichi Sankyo Business Overview
Table 102. Daiichi Sankyo Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Daiichi Sankyo Decoagulant Product
Table 104. Daiichi Sankyo Response to COVID-19 and Related Developments
Table 105. The Medicines Company Business Overview
Table 106. The Medicines Company Decoagulant Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. The Medicines Company Decoagulant Product
Table 108. The Medicines Company Response to COVID-19 and Related Developments
Table 109. Decoagulant Distributors List
Table 110. Decoagulant Customers List
Table 111. Covid-19 Impact on Decoagulant Customers
List of FiguresFigure 1. Decoagulant Product Picture
Figure 2. Decoagulant Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Decoagulant Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Decoagulant Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Decoagulant Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Decoagulant Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Decoagulant Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Decoagulant Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Decoagulant Market Size Market Share, 2019-2021